Happy Holidays and New year from the EMDB! Please be advised that the EMDB team will be operating at reduced capacity between December 15th - January 12th. With this in mind we would ask that you be prepared for longer reply times through both our helpdesk system and the OneDep deposition system. well done on a productive 2025, wishing you all the best and we will see you in 2026!

EMD-12187

Single-particle
2.9 Å
EMD-12187
3D View Gallery
Deposition: 11/01/2021
Map released: 17/02/2021
Last modified: 09/10/2024
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-12187
Download
3D volume (map.gz) Experimental metadata (xml) Experimental Metadata (cif.gz)
Map-only Validation report (pdf.gz) Map-only Validation report (cif.gz) Map-only Validation report (xml.gz)
Map and PDB model 7bh9 summary report (pdf.gz) Map and 7bh9 FULL report (pdf.gz)
EMICSS annotations (xml)

SARS-CoV-2 RBD-62 in complex with ACE2 peptidase domain

EMD-12187

Single-particle
2.9 Å
EMD-12187
3D View Gallery
Deposition: 11/01/2021
Map released: 17/02/2021
Last modified: 09/10/2024
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Homo sapiens, Severe acute respiratory syndrome coronavirus 2
Sample: SARS-CoV-2 RBD-62 in complex with ACE2 peptidase domain
Fitted models: 7bh9

Deposition Authors: Elad N, Dym O
SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution.
Zahradnik J , Marciano S, Shemesh M, Zoler E , Harari D, Chiaravalli J , Meyer B , Rudich Y , Li C, Marton I, Dym O, Elad N, Lewis MG , Andersen H , Gagne M, Seder RA , Douek DC, Schreiber G
(2021) Nat Microbiol , 6 , 1188 - 1198
PUBMED: 34400835
DOI: doi:10.1038/s41564-021-00954-4
ISSN: 2058-5276